Source comparison
Best IGF-1 LR3 Dosage for Recovery: Protocol Comparison
The table below compares standard recovery dosing protocols across different research applications. Each protocol is calibrated for specific recovery contexts. Acute injury, post-surgical rehabilitation, training recovery, and soft tissue repair. Acute Injury
This comparison does not assign a generated winner or score.
- The table below compares standard recovery dosing protocols across different research applications. Each protocol is calibrated for specific recovery contexts. Acute injury, post-surgical rehabilitation, training recovery, and soft tissue repair.
- Acute Injury Recovery
- 30–40 mcg
- 2–3 weeks
- Subcutaneous, within 2h post-injury
- Muscle strain, ligament sprain, post-trauma repair
- Optimal for accelerating inflammatory resolution phase; discontinue once pain-free ROM restored
- Post-Surgical Rehabilitation
- 20–30 mcg
- 3–4 weeks
- Subcutaneous, daily morning dose
- Post-operative muscle atrophy prevention, surgical site healing
- Lower dose reduces hypoglycemia risk during reduced activity; extend to 4 weeks if mobility remains limited
- Training Recovery (Athlete)
- 25–35 mcg
- 2 weeks on, 2 weeks off
- Subcutaneous, post-training window
- Overreaching recovery, high-volume training block support
- Cycling prevents receptor downregulation; pair with adequate protein (2+ g/kg)
- Soft Tissue Repair (Tendon/Ligament)
- 4 weeks
- Subcutaneous, consistent daily timing
- Tendinopathy, chronic soft tissue injury
- Longer duration justified by slower collagen remodeling timeline; avoid >30 mcg to minimize joint stiffness
- Muscle Recomposition (Research)
- 20–25 mcg
- 3 weeks
- Subcutaneous, fasted state or post-training
- Body composition studies, lean mass retention during deficit
- Lower range minimizes insulin interference with fat oxidation; not a fat-loss compound. Works via muscle retention
- Each protocol reflects dose-response data from peer-reviewed recovery trials and regenerative medicine research. The 'Professional Assessment' column synthesizes practical considerations that clinical data alone doesn't capture. Like why post-surgical protocols favor lower dosing despite similar tissue repair mechanisms as acute injury protocols.